A US Centers for Disease Control and Prevention (CDC)-led study identifies three clusters of post-COVID multisystem ...

Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition characterized by rapid onset of widespread inflammation in the lungs, leading to significant breathing difficulties.

InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

A few days later the teenager was admitted to intensive care after developing acute respiratory distress syndrome. “This was a healthy teenager prior to this, so no underlying conditions,” said ...

The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

H5N1, or bird flu, poses a limited risk to humans but remains a serious threat. Learn how it spreads, its symptoms, and key ...